Xu M, Xu C, Wang R, Tang Q, Zhou Q, Wu W
Genes Dis. 2025; 12(3):101313.
PMID: 40028035
PMC: 11870178.
DOI: 10.1016/j.gendis.2024.101313.
Sondergaard J, Tulyeu J, Priest D, Sakaguchi S, Wing J
Nat Commun. 2025; 16(1):1325.
PMID: 39900891
PMC: 11791207.
DOI: 10.1038/s41467-024-55746-1.
Isshiki Y, Chen X, Teater M, Karagiannidis I, Nam H, Cai W
Cancer Cell. 2024; 43(1):49-68.e9.
PMID: 39642889
PMC: 11732734.
DOI: 10.1016/j.ccell.2024.11.006.
Purzner J, Brown A, Purzner T, Ellis L, Broski S, Litzenburger U
bioRxiv. 2024; .
PMID: 39605517
PMC: 11601632.
DOI: 10.1101/2024.11.21.624171.
Fischetti I, De Luca M, Jachetti E
Epigenomics. 2024; 16(19-20):1265-1268.
PMID: 39387445
PMC: 11534139.
DOI: 10.1080/17501911.2024.2410693.
Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy.
Zhou Z, Xu J, Liu S, Lv Y, Zhang R, Zhou X
Biomark Res. 2024; 12(1):97.
PMID: 39227959
PMC: 11373505.
DOI: 10.1186/s40364-024-00630-9.
Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives.
Luo Y, Lu J, Lei Z, Zhu H, Rao D, Wang T
Biomark Res. 2024; 12(1):74.
PMID: 39080807
PMC: 11289998.
DOI: 10.1186/s40364-024-00621-w.
Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancer.
Jama M, Tabana Y, Barakat K
Eur J Med Res. 2024; 29(1):353.
PMID: 38956700
PMC: 11218087.
DOI: 10.1186/s40001-024-01901-9.
PROTAC EZH2 degrader-1 overcomes the resistance of podophyllotoxin derivatives in refractory small cell lung cancer with leptomeningeal metastasis.
Shi M, Ding X, Tang L, Cao W, Su B, Zhang J
BMC Cancer. 2024; 24(1):504.
PMID: 38644473
PMC: 11034131.
DOI: 10.1186/s12885-024-12244-3.
The Role of H3K27me3-Mediated Th17 Differentiation in Ankylosing Spondylitis.
Chen Y, Liu W, Xu X, Zhen H, Pang B, Zhao Z
Inflammation. 2024; 47(5):1685-1698.
PMID: 38517649
DOI: 10.1007/s10753-024-02002-9.
The Role of Protein Methyltransferases in Immunity.
Song C, Kim M, Cho J
Molecules. 2024; 29(2).
PMID: 38257273
PMC: 10819338.
DOI: 10.3390/molecules29020360.
Survivin prevents the polycomb repressor complex 2 from methylating histone 3 lysine 27.
Jensen M, Chandrasekaran V, Garcia-Bonete M, Li S, Anindya A, Andersson K
iScience. 2023; 26(7):106976.
PMID: 37534134
PMC: 10391610.
DOI: 10.1016/j.isci.2023.106976.
Polycomb Ezh1 maintains murine muscle stem cell quiescence through non-canonical regulation of Notch signaling.
Feng X, Wang A, Juan A, Ko K, Jiang K, Riparini G
Dev Cell. 2023; 58(12):1052-1070.e10.
PMID: 37105173
PMC: 10330238.
DOI: 10.1016/j.devcel.2023.04.005.
The Chromatin Regulator Mll1 Supports T Follicular Helper Cell Differentiation by Controlling Expression of Bcl6, LEF-1, and TCF-1.
Belanger S, Haupt S, Faliti C, Getzler A, Choi J, Diao H
J Immunol. 2023; 210(11):1752-1760.
PMID: 37074193
PMC: 10334568.
DOI: 10.4049/jimmunol.2200927.
EZH2: Its regulation and roles in immune disturbance of SLE.
Yang Y, Liu K, Liu M, Zhang H, Guo M
Front Pharmacol. 2022; 13:1002741.
PMID: 36313363
PMC: 9606410.
DOI: 10.3389/fphar.2022.1002741.
The pleiotropic roles of EZH2 in T-cell immunity and immunotherapy.
Wang Y, Bui T, Zhang Y
Int J Hematol. 2022; 116(6):837-845.
PMID: 36271224
DOI: 10.1007/s12185-022-03466-x.
Polycomb Directed Cell Fate Decisions in Development and Cancer.
German B, Ellis L
Epigenomes. 2022; 6(3).
PMID: 36135315
PMC: 9497807.
DOI: 10.3390/epigenomes6030028.
Granulocytic myeloid-derived suppressor cells to prevent and treat murine immune-mediated bone marrow failure.
Feng X, Kim J, Gonzalez-Matias G, Aggarwal N, Manley A, Wu Z
Blood Adv. 2022; 7(1):73-86.
PMID: 35895513
PMC: 9827041.
DOI: 10.1182/bloodadvances.2022007254.
Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses.
Yan J, Chen Y, Patel A, Warda S, Lee C, Nixon B
J Clin Invest. 2022; 132(17).
PMID: 35852856
PMC: 9433107.
DOI: 10.1172/JCI153437.
EZH2 Promotes T Follicular Helper Cell Differentiation Through Enhancing STAT3 Phosphorylation in Patients With Primary Sjögren's Syndrome.
He C, Yang Y, Chen Z, Liu S, Lyu T, Zeng L
Front Immunol. 2022; 13:922871.
PMID: 35795677
PMC: 9252457.
DOI: 10.3389/fimmu.2022.922871.